TrialDiabetes, obesity & metabolism2017

Efficacy and safety of sitagliptin as compared with glimepiride in Japanese patients with type 2 diabetes mellitus aged ≥ 60 years (START-J trial).

Yasuo Terauchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.